FundedIQ
Biotechnology

Neucruit: Funding, Investors & Team (Oct 2026)

Neucruit is an intelligent software for clinical trial recruitment that helps sponsors and healthcare professionals reach thousands of potential participants in one click. Our technology aggregates real-time data from the over 25 million health-related conversations initiated online everyday to facilitate planning and recruitment in clinical trials. We support biopharmaceutical companies, site teams and investigators enhance site selection, optimise recruitment materials and reach groups that cannot be easily accessed through traditional methods.

www.neucruit.com LinkedIn London, United Kingdom 11-50 employees
Biotechnology Clinical Trials Health Care Lifestyle
Total raised
$1.1M
Rounds
2
Latest
Seed
Feb 2022

Neucruit has raised $1.1M across 2 funding rounds on record, the most recent a Seed of $1.0M announced in Feb 2022.

That round is below the $8.4M median round size for Biotechnology companies tracked on FundedIQ over the last two years.

Neucruit Company Profile and Key Stats

Total funding raised
$1.1M
across 2 rounds on record
Funding rounds on record
2
Latest funding round
Seed
$1.0M in Feb 2022
Employees
11-50
reported band
Headquarters
London, United Kingdom

Latest funding round on record: Feb 2022.

Neucruit Funding Rounds

Date
Round
Amount
Seed
$1.0M
Non-equity Assistance
$100k

Neucruit raised $100k in a Non-equity Assistance announced in Dec 2021.

2 months later, a Seed of $1.0M was announced in Feb 2022.

Neucruit Founders and Leadership Team

Name
Role
Contact
Livia Ng
CEO
Locked

Contact details for the Neucruit team: 1 of 1 has an email address on file.

Start 14-day free trial →

Neucruit Funding Compared to Other Biotechnology Startups

Segment
Companies
Median round
4,185
$8.4M
5,368
$4.1M
17,153
$3.1M

Neucruit's latest round of $1.0M is below the median round in Biotechnology. Medians cover the last 24 months of disclosed rounds.

Funded Startups Like Neucruit in Biotechnology and London

Companies Similar to Neucruit

Microbiotica develops treatments involving live bacteria found in the human microbiome, aiming to identify…

Series C $40.4M

OMass Technologies is a drug discovery company exploiting novel mass spectrometry platforms to develop…

Series C $310M

HydRegen, based in Oxford, UK, is a biotech firm that offers eco-friendly alternatives for the production of…

Series A $8.0M

R1 Therapeutics is a clinical‑stage biopharmaceutical company focused on discovering and developing new drug…

Series A $3.0M

The perfect package for any general surgical trainee or resident. Progress from beginner to advanced surgical…

Undisclosed round $9.3M

Argonaute RNA company research projects build on existing intellectual property.

Undisclosed round $1.8M

An innovative C elegans company that serves the biotech, nutrition, and other industries and fields of study…

Undisclosed round $1.8M

ViaNautis, previously known as SomaServe, was established in 2018 as a separate entity from UCL under the…

Undisclosed round $23.3M

Alchemab is harnessing the naturally protective power of patient antibodies to keep people free of…

Series A $33.6M

Biodexa Pharmaceuticals is an international specialty pharmaceutical company focused on oncology and other…

Undisclosed round $3.5M

Concert Bio helps businesses create optimal microbial communities.

Undisclosed round $130k

RQ Bio is a biotechnology company that develops long-acting monoclonal antibodies against seasonal influenza…

Series A $113M

Neucruit Funding FAQs

What does Neucruit do?

Neucruit is an intelligent software for clinical trial recruitment that helps sponsors and healthcare professionals reach thousands of potential participants in one click. Our technology aggregates real-time data from the over 25 million health-related conversations initiated online everyday to facilitate planning and recruitment in clinical trials. We support biopharmaceutical companies, site teams and investigators enhance site selection, optimise recruitment materials and reach groups that cannot be easily accessed through traditional methods.

How much funding has Neucruit raised?

Neucruit has raised $1.1M across 2 rounds on record. The most recent is a Seed of $1.0M announced in Feb 2022.

When did Neucruit last raise funding?

Neucruit's most recent funding round on record is a Seed of $1.0M, announced in Feb 2022.

Who is the CEO of Neucruit?

Livia Ng is listed as CEO at Neucruit.

Where is Neucruit headquartered?

Neucruit is based in London, England, United Kingdom.

How many employees does Neucruit have?

Neucruit is in the 11-50 employee band.

How does Neucruit's funding compare to other Biotechnology startups?

Neucruit's latest round of $1.0M is below the $8.4M median round size for Biotechnology companies on FundedIQ across 4,185 tracked companies over the last two years.

About FundedIQ's Neucruit Funding Data

FundedIQ tracks announced funding rounds and refreshes this profile every week. Round dates, stages and amounts are normalised to a single format, converted to US dollars, and de-duplicated: two records of the same round announced days apart are merged, and two genuinely different rounds are kept apart on the amounts they disclose. Amounts shown are the disclosed figures only — a round announced without a number is listed and excluded from the total rather than estimated.

Employee counts are reported bands, not exact headcounts. Founder and executive names carry the job title on record. Anything we do not hold for Neucruit is left off this page rather than filled in.

14-day free trial · Cancel anytime

Know who just raised. Then know who to reach.

Startup funding intelligence on every funded startup: the round, the investors and the founders, as a file in your inbox or searchable in the app.

Radar from $49/mo · Pro from $149/mo. Card required, nothing charged until day 15, and we email you 3 days before that. Need something specific? Custom plans from $499/mo.